Questcor Pharmaceuticals up Nearly 26% on Upbeat Earnings

by Eddie Staley, Benzinga Editor
July 27, 2011 11:49 AM | 16 seconds read |
Questcor Pharmaceuticals QCOR is up nearly 26% on the upbeat earnings that were announced yesterday after the close. The company reported Q2 EPS of $0.23 vs. $0.20 Est. and revenues of $46M vs. $41.75M Est. Questcor Pharmaceuticals is currently trading at $32.64, or a gain of $6.64 or 25.54%.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Intraday UpdateMoversHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!